Total Visits

Views
A pooled analysis of two randomized, double-blind placebo-controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C genotype-1 infection68

Select a period of time:

Views

Views
July 202519
August 20250
September 20254
October 20252
November 20256
December 20254
January 20267
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Brazil12
United Kingdom5
Finland5
Austria1
Chile1
Ecuador1
Kenya1
Mexico1
Tunisia1
 

Top cities views

Views
Helsinki5
Dallas3
Araruama1
Ashburn1
Augusta1
Barquisimeto1
Batley1
Brasília1
Deer Park1
El Fahs1